American Portfolios Advisors’s Vir Biotechnology VIR Stock Holding History

American Portfolios Advisors’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.41K	Hold	125	–	–	﹤0.01%	3070
2022 Q2	$3.18K	Hold	125	–	–	﹤0.01%	2996
2022 Q1	$3.21K	Hold	125	–	–	﹤0.01%	3087
2021 Q4	$5.23K	Hold	125	–	–	﹤0.01%	2874
2021 Q3	$5.44K	Hold	125	–	–	﹤0.01%	2815
2021 Q2	$5.91K	Hold	125	–	–	﹤0.01%	2745
2021 Q1	$6.41K	Sell	125 -149	-54%	-$8.03K	﹤0.01%	2593
2020 Q4	$7.34K	Buy	274 +250	+1,042%	+$8.13K	﹤0.01%	2256
2020 Q3	$824	Hold	24	–	–	﹤0.01%	2794
2020 Q2	$983	Hold	24	–	–	﹤0.01%	2685
2020 Q1	$822	Buy	+24	New	+$645	﹤0.01%	2590

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Portfolios Advisors's VIR Position: Q3 2022 in Review

American Portfolios Advisors held its Vir Biotechnology (VIR) position steady in Q3 2022 at 125 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3070.

American Portfolios Advisors first reported a position in VIR in Q1 2020 and has held it in 11 quarters since. The position peaked at $7.34K in Q4 2020. 220 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

American Portfolios Advisors held 125 shares of Vir Biotechnology worth $2.41K as of Q3 2022.
American Portfolios Advisors left its Vir Biotechnology share count unchanged in Q3 2022.
Vir Biotechnology made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3070 holding.
American Portfolios Advisors first reported a position in Vir Biotechnology in Q1 2020 and has held it in 11 quarters since.
American Portfolios Advisors's Vir Biotechnology position peaked at $7.34K in Q4 2020.
220 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.